| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1994;107:615-0620
© 1994 Mosby, Inc.
General Thoracic Surgery |
Taichung, Taiwan, Republic of China
From the Division of Thoracic Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China.
Received for publication April 20, 1993. Accepted for publication July 7, 1993. Address for reprints: Chung-Ping Hsu, MD, Division of Thoracic Surgery, Department of Surgery, Taichung Veterans General Hospital, #160, Sec. 3, Taichung-Kang Road, Taichung, Taiwan, Republic of China.
Abstract
Thymic carcinoma is a rare neoplasm with extremely poor prognosis. To evaluate the outcome of treatment in thymic carcinoma, we reviewed a 10-year (1982 to 1992) experience with 20 consecutive patients in Taichung Veterans General Hospital. There were 9 men and 11 women: ages ranged from 34 to 70 years old (mean 51.4 years). None of these patients had concomitant myasthenia gravis. All of the patients received surgical intervention, and the diagnosis was made by pathologic study. Postoperative staging was made according to the modified Masaoka staging system. None of our patients were in stage I. One patient (5%) had stage II disease, 12 (60%) stage III, and 7 (35%) stage IV. The pathologic subtypes of thymic carcinoma included eight squamous cell carcinomas, seven undifferentiated carcinomas, one lymphoepithelioma-like carcinoma, one clear-cell carcinoma, 1 mucoepidermoid carcinoma, and two carcinoid tumors. Curative resection could be done in seven patients (35%). The overall cumulative survival was 45.9% at 3 years and 34.4% at 5 years. The median survival times for patients with complete and incomplete resection were 39.0 months and 14.3 months, respectively (p = 0.1752). The median survival times of patients with postoperative radiotherapy and without postoperative radiotherapy were 39.3 months and 15.0 months, respectively (p = 0.0738). The median survival times of patients with squamous cell carcinoma and undifferentiated carcinoma were 25.4 months and 11.3 months, respectively (p = 0.1464). Our data show that complete resection, postoperative radiotherapy, and squamous cell carcinoma do not indicate a significantly favorable result, even though they result in longer median survival times. Yet a positive trend of favorable outcome in patients who received postoperative radiotherapy is ambiguously shown. (J THORAC CARDIOVASC SURG 1994;107:615-20)
This article has been cited by other articles:
|
|
 |
|
  K. Nakagawa, Y. Matsuno, H. Kunitoh, A. Maeshima, H. Asamura, and R. Tsuchiya Immunohistochemical KIT (CD117) Expression in Thymic Epithelial Tumors Chest, July 1, 2005; 128(1): 140 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nonaka, Y. Tamaki, K. Higuchi, H. Katoh, M. Nakahashi, H. Horikoshi, K. Takahashi, K. Minato, S. Sugihara, and M. Kojima The Role of Radiotherapy for Thymic Carcinoma Jpn. J. Clin. Oncol., December 1, 2004; 34(12): 722 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Baran, C. M. Magro, M. A. King, T. E. Williams Jr, and P. Ross Jr Atypical thymoma: A report of seven patients Ann. Thorac. Surg., August 1, 2004; 78(2): 411 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Takeda, N. Sawabata, M. Inoue, M. Koma, H. Maeda, and H. Hirano Thymic carcinoma. Clinical institutional experience with 15 patients Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 401 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. Detterbeck and A. M. Parsons Thymic tumors Ann. Thorac. Surg., May 1, 2004; 77(5): 1860 - 1869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kondo and Y. Monden Lymphogenous and hematogenous metastasis of thymic epithelial tumors Ann. Thorac. Surg., December 1, 2003; 76(6): 1859 - 1864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-L. Tseng, S.-T. Wang, M.-H. Wu, M.-Y. Lin, W.-W. Lai, and F.-F. Cheng Thymic carcinoma: involvement of great vessels indicates poor prognosis Ann. Thorac. Surg., October 1, 2003; 76(4): 1041 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kondo and Y. Monden Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan Ann. Thorac. Surg., September 1, 2003; 76(3): 878 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Greene and M. A. Malias Aggressive multimodality treatment of invasive thymic carcinoma J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 434 - 436. [Full Text] [PDF]
|
|
|
|
|
|
H.-C. Liu, W.-H. Hsu, Y.-J. Chen, Y.-J. Chan, Y.-C. Wu, B.-S. Huang, and M.-H. Huang Primary thymic carcinoma Ann. Thorac. Surg., April 1, 2002; 73(4): 1076 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kitami, T. Suzuki, Y. Kamio, and S. Suzuki Chemotherapy of Thymic Carcinoma: Analysis of Seven Cases and Review of the Literature Jpn. J. Clin. Oncol., December 1, 2001; 31(12): 601 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Refaely, D. A. Simansky, M. Paley, M. Gottfried, and A. Yellin Resection and perfusion thermochemotherapy: a new approach for the treatment of thymic malignancies with pleural spread Ann. Thorac. Surg., August 1, 2001; 72(2): 366 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lucchi, A. Mussi, F. Basolo, M. C. Ambrogi, G. Fontanini, and C. A. Angeletti The multimodality treatment of thymic carcinoma Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 566 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-J. Jung, K. S. Lee, J. Han, J. Kim, T. S. Kim, and E. A. Kim Malignant Thymic Epithelial Tumors: CT-Pathologic Correlation Am. J. Roentgenol., February 1, 2001; 176(2): 433 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakamura, H. Kunitoh, K. Kubota, I. Sekine, T. Shinkai, T. Tamura, T. Kodama, M. Sumi, S. Kohno, and N. Saijo Platinum-based Chemotherapy with or without Thoracic Radiation Therapy in Patients with Unresectable Thymic Carcinoma Jpn. J. Clin. Oncol., September 1, 2000; 30(9): 385 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Masaoka, Y. Yamakawa, and Y. Fujii Well-differentiated thymic carcinoma: Is it thymic carcinoma or not? J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 628 - 630. [Full Text]
|
|
|
|
|
|
E. A. Bacha, A. R. Chapelier, P. Macchiarini, E. Fadel, and P. G. Dartevelle Surgery for invasive primary mediastinal tumors Ann. Thorac. Surg., July 1, 1998; 66(1): 234 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Regnard, F. Zinzindohoue, P. Magdeleinat, L. Guibert, L. Spaggiari, and P. Levasseur Results of Re-resection for Recurrent Thymomas Ann. Thorac. Surg., December 1, 1997; 64(6): 1593 - 1598. [Abstract] [Full Text]
|
|
|
|
|
|
V. T. de Montpreville, P. Macchiarini, and E. Dulmet THYMIC NEUROENDOCRINE CARCINOMA (CARCINOID): A CLINICOPATHOLOGIC STUDY OF FOURTEEN CASES J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 134 - 141. [Abstract] [Full Text]
|
|
|
|
|
|
D. Blumberg, J. L. Port, B. Weksler, R. Delgado, J. Rosai, M. S. Bains, R. J. Ginsberg, N. Martini, P. M. McCormack, V. Rusch, et al. Thymoma: A Multivariate Analysis of Factors Predicting Survival Ann. Thorac. Surg., October 1, 1995; 60(4): 908 - 913. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
